Research & Innovation Services
Paul Giacomin
- Research Development and Partnership Advisor
- paul.giacomin@jcu.edu.au
Arnold Mangott
- Research Development and Partnership Advisor
- arnold.mangott@jcu.edu.au
Personal Protective Biosystems - Membranes and commensal helminths (MaCH) (Old ID 26776)
Paul Giacomin
15 Apr 2021 - 14 Apr 2026
The proposed work will design a 2-part protective biosystem capable of dramatically reducing the burden of personal protective equipmetn (PPE). The first component consists of a garmetn system with a dynamic, selectively permeable graphene composite barrier laqyer and integrated self-cleaning functionality provided by metal oranic frameworks. The sedon component (including work to be done at JCU) leverages genetic modification of human helminth parasites (hookworms and/or schistosomes) to provide prophylaxis and neutralisation of various chemical and/or biological agents.
Novel biologics for pediatric inflammatory bowel disease and necrotising enterocolitis, inspired by host-parasite co-evolution. (Old ID 27128)
Paul Giacomin
01 Feb 2021 - 31 Aug 2022
Inflammatory bowel diseases (IBD) pose a major health burden with severe symptoms, and IBD onset in childhood is on the rise. Necrotising enterocolitis (NEC) is another inflammatory bowel condition that affects preterm infants, and in which inflamed parts of the gut die. Current treatment methods are insufficient. Intestinal parasites have developed strategies to modulate our immune responses through secreted proteins. We identified seven helminth-secreted proteins that suppress gut inflammation. We now would like to assess which of our preselected proteins are best in the context of early life IBD and NEC.
Treatment of mice with S4B6 IL‑2 complex prevents lethal toxoplasmosis via IL‑12‑ and IL‑18‑dependent interferon‑gamma production by non‑CD4 immune cells
- 2020
- Nature Publishing Group
- Researchers:Andreas KupzPaul GiacominKate Miller
Helminth coinfection and COVID-19: an alternate hypothesis
- 2020
- Public Library of Science
- Researchers:Doris PiercePaul GiacominAlex LoukasRobyn McDermott
Gastrointestinal helminth infection improves insulin sensitivity, decreases systemic inflammation, and alters the composition of gut microbiota in distinct mouse models of Type 2 diabetes
- 2021
- Frontiers Research Foundation
- Researchers:Andreas KupzMatt FieldNorelle DalyPaul GiacominAlex Loukas
Randomized, placebo controlled trial of experimental hookworm infection for improving gluten tolerance in Celiac disease
- 2020
- Wolters Kluwer Health, Inc
- Researchers:Alex LoukasPaul Giacomin
Immune system investigation using parasitic helminths
- 2021
- Annual Reviews
- Researchers:Paul Giacomin
Start Date:
01 Jan 2016
End Date:
01 Jan 2019
Start Date:
01 Jan 2012
End Date:
01 Jan 2015
Start Date:
01 Jan 2010
End Date:
01 Jan 2012
Start Date:
01 Jan 2009
End Date:
01 Jan 2009
Start Date:
01 Jan 2008
End Date:
01 Jan 2009
Start Date:
01 Jan 2003
End Date:
01 Jan 2008
Start Date:
01 Jan 2002
End Date:
01 Jan 2002
Start Date:
01 Jan 1999
End Date:
01 Jan 2002
